TRXD - Trxade Group, Inc.
| Previous Close | 1.1000 |
| Open | 1.1000 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 1.1000 - 1.1000 |
| 52 Week Range | 0.2300 - 1.6000 |
| Volume | 90 |
| Avg. Volume | 3,729 |
| Market Cap | 39.299M |
| Beta (3Y Monthly) | 1.37 |
| PE Ratio (TTM) | 366.67 |
| EPS (TTM) | 0.0030 |
| Earnings Date | Nov 3, 2016 - Nov 4, 2016 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 0.70 |
- MoneyShow
Trxade Eyes B2B in Pharmacies
Faris Sleem, editor of The Bowser Report, is a leading specialist in low-priced, micro-cap stocks; indeed, his latest featured recommendation had 2018 revenues of just $3.8 million.
- GlobeNewswire
Trxade Group Generates Record Revenues in Second Quarter 2019
Revenue Growth of 129% to $1.9 MillionOperating Income Growth of 322% to $132,7051st Half 2019 EPS of $0.01 TAMPA, FL, July 29, 2019 -- Trxade Group, Inc. (OTCQB: TRXD), an.
- GlobeNewswire
TRXADE GROUP, INC, S-1 REGISTRATION DECLARED EFFECTIVE
Trxade Group, Inc. (TRXD), Trxade is an integrated pharmaceutical logistical services company that combines a web-based purchasing platform for transactions between independent pharmacies and drug manufacturers, MSO with a specialty pharmacy, and a warehouse and drug delivery service for consumers. Trxade is pleased to announce that the registration statement on Form S-1 (the "S-1 Registration Statement") previously filed with the Securities and Exchange Commission (the "SEC") was declared effective by the SEC today, July 2nd, 2019. This S-1 Registration Statement covers the resale from time to time by the selling shareholders identified in the S-1 Registration Statement for up to 31,949,712 shares of our common stock.
- GlobeNewswire
TRXADE GROUP SUBSIDIARY COMMUNITY SPECILAITY PHARMACY PASSES RIGOROUS REVIEW PROCESS TO EARN LEGITSCRIPT CERTIFICATION
Trxade Group, Inc. (TRXD), Trxade is an integrated pharmaceutical logistical services company that combines a web-based purchasing platform for transactions between independent pharmacists and drug manufacturers, MSO with a Specialty pharmacy. Trxade has warehouse and drug delivery services for consumers further advanced capabilities today by announcing that company’s subsidiary Community Specialty Pharmacy (https://www.comsprx.com ) has secured its certification with LegitScript.
- ACCESSWIRE
Trxade Group Achieves Record First Quarter 2019 Financial Results Driven By An Increase In Revenues
First Quarter Highlights: Company achieves record revenues of $1.512 million in quarter ending March 31, 2019 an increase from $852,923 in quarter ending March 31, 2018 Operating Income Increased to $171,759 ...
- GlobeNewswire
Coverage Initiated for Trxade Group Inc. via NetworkNewsWire
NEW YORK, April 23, 2019 -- via NetworkWire - Trxade Group Inc. (OTCQB: TRXD), an integrated drug purchasing and delivery platform that enables trade among healthcare buyers.
- GlobeNewswire
Trxade Group, Inc. Reports Fourth Quarter and Full Year 2018 Results
TAMPA, Fla., March 26, 2019 -- Trxade Group, Inc., (OTCQB: TRXD) is an integrated drug purchasing and delivery solutions company with a market platform that enables trade among.
- GlobeNewswire
Trxade Group Launches its MSO Pharmacy Network and Surpasses 10,000 Independent Retail Pharmacy Members
Expected to Drive Revenue Growth in 2019 TAMPA, FL, Feb. 25, 2019 -- February 25, 2019 – Trxade Group, Inc. (OTCQB: TRXD) (“Trxade” or the “Company”), an integrated drug.
- GlobeNewswire
Trxade Group to Exhibit its Trading Procurement Platform for Healthcare Buyers and Sellers at HIMSS19
TAMPA, FL, Feb. 07, 2019 -- Trxade Group, Inc. (OTCQB: TRXD) (“Trxade” or the “Company”), an integrated healthcare platform, announced today its participation in the Healthcare.
- GlobeNewswire
Trxade Group and PanOptic Health to Launch SyncHealth Joint Venture
A Revolutionary Technology Solution to Empower Independent Retail Pharmacies TAMPA, FL, Jan. 22, 2019 -- Trxade Group, Inc. (OTCQB: TRXD) (“Trxade” or the “Company”), an.
- GlobeNewswire
Trxade Group Engages Hayden IR to Launch Comprehensive Investor Relations Program
Focused on Increasing Awareness and Enhancing Shareholder Value TAMPA, FL, Jan. 03, 2019 -- Trxade Group, Inc. (OTCQB: TRXD) (“Trxade” or the “Company”), a web-based.
- ACCESSWIRE
Trxade Group, Inc to Present at the 11th Annual LD Micro Main Event
LOS ANGELES, CA / ACCESSWIRE / November 19, 2018 / Trxade Group, Inc., ( OTCQB: TRXD ) the trusted B2B market place for 9,300 registered independent pharmacy customers that enables its customers to quickly ...
- GlobeNewswire
Trxade Group, Inc. Reports Third Quarter Fiscal 2018 Results
Achieved 15% Revenue growth from year-over-year periods and the seventh consecutive quarter of positive operating incomeCompleted a strategic acquisition of a retail specialty.